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Objective: Bacterial vaginosis (BV) is characterized by a shift in vaginal tract ecology, which includes a decrease
in the concentration and/or prevalence of facultative lactobacilli. Currently, mechanisms which could account
forthedisappearanceoflactobacilliarenotwellunderstood.Theobjectiveofthisstudywastodeterminewhether
vaginal streptococci/enterococci can produce bacteriocin-like inhibitors antagonistic to vaginal lactobacilli.
Methods: Seventy strains of vaginal streptococci or enterococci were tested for antagonistic activities against
vaginal lactobacilli using the deferred antagonism technique.
Results: One strain, Enterococcus faecium 62-6, which strongly inhibited growth of lactobacilli was selected for
further characterization. The spectrum of inhibitory activity of strain 62-6 included Gram-positive organisms
from the vaginal environment, although native lactobacilli from the same host were resistant to inhibitor action.
FollowinggrowthinMRSbroththestrain62-6inhibitorwasshowntobeheat-(100°C,30 minutes),cold-(4°C,less
than 114 days) and pH- (4–7) stable. The sensitivity of inhibitor-containing supernatants to pepsin and
α-chymotrypsinsuggestedanessentialproteinaceouscomponent.Theinhibitorwassensitivetolipasebutresistant
to lysozyme. Dialysis of inhibitor-containing culture supernatants suggested a molecular mass greater than
12 000 Da. All physicochemical properties were consistent with its classification as a bacteriocin-like inhibitor.
Kinetic assays demonstrated a sharp onset of inhibitor production coinciding with a concentration of 62-6 of
10
7 cfu/ml, suggesting that production may be regulated by quorum sensing.
Conclusions: Theseresultsmayhaveclinicalsignificanceasanovelmechanismtoaccountforthedeclineofvaginal
Lactobacillus populations and contribute to both the establishment and recurrence of BV.
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Bacterial vaginosis (BV) is the most common
vaginal tract infection seen in women of repro-
ductive age in primary health care1. BV has a
complexmicrobiology,characterizedbyanaltered
ecology of the vaginal tract which is reflected by
the composition of the microflora. Lactobacillus
populations, which are usually dominant in
healthy women, are replaced by a polymicrobial
group of organisms which includes the facultative
organism Gardnerella vaginalis, Gram-positive and
Gram-negative anaerobes, the genital myco-
plasmasandsometimesMobiluncusspecies2.During
BV, total counts of aerobes and anaerobes are
elevated 100- and 1000-fold, respectively, over
normal levels3. However, the factor(s), either
endogenous or exogenous, that initiate the shift in
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 2003 The Parthenon Publishing Group 147the ecology of the vagina and result in the massive
overgrowth of these microorganisms are not
well-understood2,4.
Interest in understanding the pathogenesis of
BV stems from its clinical association with adverse
pregnancy outcome1,5, pelvic inflammatory
disease6, postoperative infections following
gynecologic and obstetric surgeries7 and increased
risk of HIV acquisition via heterosexual inter-
course8–10. While various antibiotic regimens for
the treatment of BV are available, relapse rates
are notoriously high1,5. Recurrence rates have
been reported as high as 80% within a year
of therapy11 and 50% 5 to 9years following
treatment12. The failure of antibiotic treatment
may reflect, in part, our limited understanding of
theecologyofthevaginaltractincludingmicrobial
interactions of significance during both health
and BV.
One of the commonly-recognized, but poorly
understood, features in the shift from a normal to a
BV-associated flora is that the facultative lacto-
bacilli lose their dominance as indicated by the
decrease in their concentration and/or prevalence
in vivo1,2,4,7,13. Results from one clinical study
suggest that Lactobacillus populations are one of
the first populations to decline in a sequence of
population changes in the vagina leading to the
establishment of BV14. Only a few studies have
soughtecologically-basedexplanations,inparticu-
lar microbial interactions, which could contribute
to the decline in concentration and/or prevalence
of facultative lactobacilli in the context of under-
standingthepathogenesisofBV.Notably,Taoand
co-workers have reported the production of both
phage (from vaginally- and environmentally-
derived lactobacilli) and possible bacteriocins
produced by lactobacilli from nonvaginal
sources, which inhibit the growth of vaginal
lactobacilli15–17.
Sexual experience, especially exposure to a new
sex partner or multiple sex partners, has been a
strongly documented risk factor for BV1. Sexual
contact provides an opportunity for micro-
organisms to be introduced into the vagina. Strains
of streptococci and enterococci from many differ-
ent sources have been well documented for their
ability to produce bacteriocins or bacteriocin-like
inhibitory substances18–20. Since these genera are
components of the healthy vaginal microflora21,22,
they have the potential of establishing themselves
if introduced into a new host. In addition,
should they be bacteriocin producers, they have
the potential of disrupting the microflora of their
newhost.Withthisinmind,theaimofthecurrent
study was to test streptococcal and enterococcal
isolates of vaginal origin for the production of
bacteriocin-like inhibitors antagonistic to the
growth of vaginal lactobacilli. The discovery of
inhibitor-producing strains with the potential of
establishing themselves in a new host would be a
novel mechanism to account for the decline of
the vaginal lactobacilli, thus potentially paving the
way for the establishment of a BV-associated
microflora. This study reports the characterization
of a bacteriocin-like inhibitor produced by a
vaginally-derived isolate of Enterococcus, E. faecium
strain 62-6, which was shown to be antagonistic
to the growth of vaginal lactobacilli.
MATERIALS AND METHODS
Bacterial strains and culture conditions
Bacteria were isolated from discarded routine
blood agar (BA) and chocolate agar culture plates
obtained from both overtly healthy, including
pregnant, and symptomatic women of menarchal
age presenting for vaginal examination in
physicians’ offices in Kalamazoo County and sent
to Bronson Hospital, Kalamazoo, MI. Vaginal
cultures were plated on both BA and chocolate
agar and cultivated in a humid atmosphere at 35°C
in the presence of 5% (v/v) CO2 (standard
conditionsofincubation)andprovidedtousbythe
Department of Clinical Microbiology, Bronson
Hospital. Culture plates were accompanied by
briefinformationincludingageofpatient,whether
or not she was pregnant, plus a brief description
of the vaginal diagnosis and/or a summary of
the main organisms present, as assessed by the
Department of Clinical Microbiology. Patient
names were kept confidential and not released
to us.
Cultivation in liquid media was routinely
carried out using 7 ml volumes of Lactobacilli
MRS (MRS; Difco, Detroit, MI) broth or Brain
Heart Infusion (BHI; Difco). BA containing 5%
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Isle, PA) and MRS agar (MRS broth containing
1.5%agar)werethesolidcultivationmedia.Unless
stated otherwise, routine cultivation was over-
night (18–20 hours) under standard conditions of
incubation. Anaerobic conditions were generated
using the BBL Gas Pak Anaerobic System
(Sparks, MD).
Identification of bacteria
All isolates of vaginal bacteria were tentatively
identified to genus level. Gram-positive, catalase-
positive cocci were classified as belonging to the
genus Streptococcus or Enterococcus and Gram-
positive, catalase-positive elongated rods were
considered Lactobacillus spp. Lactobacillus isolates
1-1,4-1,7-1,9-1,20-3,33-4,46-1and46-4were
identified as L. acidophilus, strain 62-5 as L. casei
subsp.rhamnosusandstrain62-6asE.faeciumbythe
Michigan Department of Community Health,
Lansing, MI. The enterococcal isolate 46-2 was
identified as E. faecalis at Bronson Hospital. Stock
cultures of each strain were prepared by the
addition of glycerol (final concentration, 10% v/v)
to overnight MRS broth cultures for the lacto-
bacilli and BHI cultures for the streptococci and
enterococci and stored at −80°C.
The deferred antagonism technique for
detection of bacteriocin-like inhibitors on solid
media
This was essentially carried out according to Tagg
andBannister23.Seventystreptococcalandentero-
coccal strains of vaginal origin (potential producer
strains) were grown on BA overnight as 1-cm-
wide diametric streak cultures. Following the
removal of visible growth, each plate was surface-
sterilized by exposure to chloroform vapors,
then air dried for at least 30 minutes. Thirty-two
overnight cultures of Lactobacillus indicator
bacteria, also of vaginal origin, were applied at
right angles to the diametric streak cultures using
a cotton-tipped swab. Plates were incubated
then examined after 20 and then 44 hours’ incuba-
tion for any zones of growth inhibition of the
indicator bacteria.
Detection of bacteriocin-like activity in liquid
preparations
The well diffusion technique24 was used to detect
the inhibitory activity of liquid preparations,
including culture supernatants, following addition
of a standard volume of 100 µl to each well.
Plates were surface-sterilized as above. Following
application of indicator bacteria, plates were
incubated for 20 and 44 hours before being
examined for the presence of zones of inhibited
growth in the vicinity of each well. The diameter
of any zone of inhibition, including the 5 mm
diameter of the well, was measured in mm. For
both bacteriocin detection assays, indicator
bacteria were cultured overnight in MRS broth.
Stability of the anti-lactobacillus inhibitor
produced by E. faecium 62-6
Theheat,coldandenzymestabilityoftheinhibitor
was tested using culture supernatants by conven-
tional methods. For the enzyme susceptibility
assays, culture supernatants were diluted 1:1 with
thefollowingenzymespreparedataconcentration
of 2 mg/ml in phosphate (pH 7.0 and 8.0) or
citratebuffer(pH3.0)atthepHvaluesindicatedin
parentheses: trypsin (Type II-S, porcine pancreas;
7.0), pepsin (porcine stomach mucosa; 3.0 and
7.0), proteinase K (Tritrachium album; 7.0),
α-chymotrypsin (Type II, bovine pancreas; 8.0),
catalase (bovine liver; 7.0), lysozyme (chicken egg
white; 7.0) and lipase (Candida rugosa; 7.0). All
enzymes were obtained from Sigma-Aldrich
Company (St. Louis, MO). Exposure to catalase
was also tested at the final concentrations of
30 µg/ml25and540 µg/ml26.ThepHsensitivityof
the inhibitor-containing culture supernatants was
tested using two methods. For the first method
theywereadjustedtopHvaluesof4.0,5.0,6.0and
7.0 using a 1:1 dilution in either citrate (for pH 4.0
and 5.0) or phosphate (for pH 6.0 and 7.0) buffer,
then assayed for inhibitory activity. For the second
method, they were adjusted to pH values of either
4.0, 5.0, 6.0 and 7.0 using 0.1M HCl or NaOH,
exposed for 1 hour at room temperature, then
readjusted to the original pH before being assayed
for inhibitory activity. Inhibitory activity was
tested using the well diffusion assay.
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inhibitor
Volumes, 3 ml, of inhibitor-containing super-
natant were loaded into dialysis bags of molecular
mass cut-off 3500 Da (Fisherbrand, Pittsburgh,
PA), 8000 Da (Sigma-Aldrich) and 12 000 Da
(Fisherbrand) and dialyzed against 300 ml volumes
of citrate buffer, pH 5.0, at 4°C. The buffer
solution was changed at least four times over
48 hours before assaying the dialyzed samples for
inhibitory activity.
Kinetics of strain 62-6 inhibitor production
The production of the bacteriocin-like inhibitor
and concentration of the producer strain E. faecium
62-6 were monitored following inoculation of
20 ml volumes of MRS broth. Samples, 0.5 ml,
werecollectedat0,1,2,3,4,5,6,10and24 hours
following inoculation. Each sample was assayed
by well diffusion for the presence of inhibitory
activity and by plate count for the concentration
of strain 62-6.
Statistical analysis
Sigma Plot (SPSS Science software products,
Chicago, IL) was used for statistical analysis of the
kinetic data. Throughout, all results represent the
minimum of two independent experiments.
RESULTS
Screening for bacteriocin production against
vaginal lactobacilli
Seventy vaginally-derived strains of bacteria
belonging to the genera Streptococcus and
Enterococcus were tested for their ability to produce
bacteriocin-like inhibitors against 32 isolates of
vaginal lactobacilli using the deferred antagonism
technique on BA. Three strains (46-2, 62-6 and
78-1) inhibited the growth of at least half of the
Lactobacillus indicator strains. Moreover, the zones
of growth inhibition were reproducible and
generally wide (extending up to 3 mm beyond
the original producer streak). Of these three
strong inhibitor producers, strain 62-6, identified
as E. faecium, was selected for characterization of
the nature of the inhibitory activity.
Spectrum of inhibitory activity of E. faecium
strain 62-6
Strain 62-6 was shown to inhibit the growth of
16 of the 32 vaginal Lactobacillus indicator strains
tested (Table 1). The spectrum of inhibitory
activity of strain 62-6 was then tested against a
further15Gram-positivebacteriaisolatedfromthe
vaginal environment as well as 15 Gram-positive
and Gram-negative bacteria from various type
culture collections (Table 1). Strain 62-6 was
shown to inhibit the growth of four of the
vaginally-derived bacteria, including three of
five streptococci/enterococci and one of five
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Indicator strain*
No. of strains
inhibited/
no. tested
Vaginal microflora isolates:
Lactobacillus spp.
Streptococcus/Enterococcus spp.
Corynebacterium spp.
Staphylococcus spp.
Type cultures:
Citrobacter freuendii PI 239
Corynebacterium xerosis ATCC 373
Edwardsiella tarda PI 296
Enterobacter aerogenes PI 341
Enterobacter cloacae PI 343
Escherichia coli ATCC 4157
Proteus mirabilis ATCC 7002
Proteus vulgaris ATCC 13315
Providencia alcalifaciens PI 368
Pseudomonas aeruginosa ATCC 10145
Serratia marsescens PI 361
Staphylococcus aureus ATCC 25923
Staphylococcus epidermidis ATCC 14990
Streptococcus mutans ATCC 25175
Streptococcus salivarius
16/32
3/5
1/5
0/5
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
0/1
*Sources: vaginal microflora and Streptococcus salivarius were
isolated in this laboratory; PI, Presque Isle Cultures, Presque Isle,
PA; ATCC, American Type Culture Collection, Manassas, VA
Table 1 Spectrum of inhibitory activity of E. faecium
strain 62-6 against bacteria isolated from the vaginal
microflora and various bacteria from type culture
collections, as detected using the deferred antagonism
technique on BAcorynebacteria tested, but none of the vaginal
staphylococci or any of the type cultures.
Production and detection of the strain 62-6
inhibitor on blood-free culture media
The bacteriocin-like inhibitory activities of
certain strains of streptococci and enterococci
have been previously shown to be dependent on
the presence of blood in the production and/or
detection media23,27. The ability to produce
inhibitors in blood-free, liquid cultivation media
is advantageous for future physicochemical
characterization assays of the inhibitor as well as its
chemical purification. Therefore, the production
of inhibitory activities by strain 62-6 was tested
following growth in the blood-free liquid culture
media MRS broth and BHI against a represent-
ative group of six out of the original 16 sensitive
Lactobacillus indicator strains: 1-1, 4-1, 7-1, 9-1,
20-3, 33-4, plus the negative control strain 62-5
(Table 2). When MRS broth was used as the
production medium and BA as the detection
medium, MRS culture supernatants inhibited the
growth of all sensitive Lactobacillus indicator
strains, as we had observed in the original deferred
antagonismtest.Incontrast,whenBHIwasusedas
the medium for production and BA for detection,
inhibitory activities were limited to indicators
4-1 and 33-4. This was the same inhibitory
pattern observed when MRS agar was used as the
detection medium, irrespective of the production
medium. Thus, strain 62-6 appears to produce
certain metabolites during growth in MRS broth
which could only be detected on BA by indicators
1-1, 7-1, 9-1 and 20-3 but not on MRS agar. The
nature of these BA-dependent inhibitory effects
was not further characterized as part of this study.
FromthispointonwardsLactobacillusstrain4-1was
usedastherepresentativepositivecontrolstrainfor
detection of inhibitory activity by strain 62-6 on
MRS agar as its sensitivity was independent of the
presence of blood. Strain 62-5 was used as the
negative control strain.
Distinction from other antibacterial inhibitors
Control experiments were performed to exclude
thepossibilitythattheinhibitoryactivityproduced
by strain 62-6 was due to conditions of low pH
alone, which can also cause antibacterial effects28.
The pH of uninoculated MRS broth and BHI is
6.2 and 7.3, respectively, which reduces to pH
values of 4.8 and 5.7 following growth of strain
62-6 under standard conditions of incubation.
Uninoculated MRS broth and BHI were adjusted
to pH values in the ranges 4.0–6.5 and 4.5–7.0,
respectively. When assayed by well diffusion
indicator strains 4-1 and 62-5 were resistant to all
pHvaluestested,irrespectiveofgrowthmedium.
AsH2O2productionhasbeenwelldocumented
to produce bacteriocin-like inhibitory effects18,
twodifferentassayswerecarriedouttoexcludethe
possibility that the observed inhibition was due to
H2O2 production. Firstly, as H2O2 is not produced
anaerobically18 strain 62-6 was grown in MRS
broth under anaerobic conditions of incubation
before testing for inhibitory activity. The pattern
of inhibition was shown to be the same as that
produced under standard (5% CO2) incubation
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Agar detection
medium
Liquid production
medium
Growth inhibition* of Lactobacillus indicator strain
1-1 4-1 7-1 9-1 20-3 33-4 62-5
BA
MRS agar
MRS
BHI
MRS
BHI
+
−
−
−
+
+
+
+
+
−
−
−
+
−
−
−
+
−
−
−
+
+
+
+
−
−
−
−
*As assessed by measurement of the diameter (mm) of the zone of the inhibited growth of the indicator strain, inclusive of the well
diameter (5 mm), where ‘+’ indicates a diameter of the zone of growth inhibition of 7 mm or greater and ‘−’ indicates a diameter of
inhibited growth of less than 7 mm
Table 2 Production of inhibitory activity in the blood-free liquid culture media, MRS broth and BHI, by E. faecium
strain 62-6 against representative vaginal Lactobacillus indicator strains, as detected on BA and MRS agar by well
diffusionconditions (Table 3). To test this further, catalase
was added to strain 62-6 culture supernatants
prior to assay for inhibitory activity. Exposure to
catalase had no demonstrable effect on inhibition
production by strain 62-6 (Table 3), thus, the
growth antagonistic activities by strain 62-6
appeared to be independent of H2O2 production.
Assessment of the sensitivity of endogenous
lactobacilli
In an attempt to assess the potential ecological
significance of strain 62-6 inhibitor production
in vivo, we tested whether a Lactobacillus isolate,
strain 62-5, obtained from the same subject as the
producer strain (62-6) was resistant or sensitive to
the inhibitor. This was repeated using Lactobacillus
strains46-1and46-2isolatedfromanotherwoman
who also carried an inhibitor-producing strain of
Enterococcus, E. faecalis 46-2 (Table 4). For both
women tested, the endogenous strains of lacto-
bacilli were immune to the action of the producer
strain from the same host when tested by both the
deferred antagonism and well diffusion assays.
Physicochemical characterization of strain
62-6 inhibitor
The physicochemical properties of the inhibitor
produced by strain 62-6 were tested and the
molecular mass estimated (Table 3). The inhibitor
appeared heat stable following boiling for
30 minutes but not autoclaving, and was stable
in MRS culture supernatants at 4°C for over
3 months. To test whether the inhibitor contained
an essential proteinaceous component, inhibitor-
containingsupernatantswereexposedtoapanelof
proteolytic agents. The inhibitor was sensitive to
pepsin and to α-chymotrypsin but resistant to the
proteases trypsin and proteinase K. In addition, it
was resistant to lysozyme but sensitive to lipase.
The strain 62-6 inhibitor was stable following
exposure to conditions of acid pH, including
pH values characteristic of the vagina during
both health and BV (4.0 and 4.5, respectively).
Inhibitory activity did not pass through a 0.22 µm
cellulose membrane during filtration, which
eliminated this procedure as a means of obtaining
sterile, inhibitor-containing culture supernatants.
A preliminary estimate of the molecular mass
following dialysis of culture supernatants in
membranes with pore sizes up to 12 000 Da
showed the retention of inhibitory activity in all
three membranes, possibly indicating a mass
greater than 12 000 Da.
Kinetics of inhibitor production
Thekineticsofinhibitorproductionbystrain62-6
are shown in Figure 1. Results from each of the
three experiments consistently detected inhibitory
activity at about 4 hours following inoculation,
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Inhibitory activity of culture
supernatants following
Growth inhibition*
of indicator strain
4-1 62-5
No treatment, positive control
Anaerobic incubation
Exposure to 50, 60, 80 or 100°C for
30 minutes
Storage at 4°C for < 114 days
Autoclaving, 121°C 15 minutes
Exposure to:
trypsin
pepsin
α-chymotrypsin
proteinase K
lysozyme
lipase
catalase
Exposure to pH 4–7
Filtration through a 0.22 µm cellulose
membrane
Dialysis in membranes of molecular
mass cut-off:
3500
8000
12 000
+
+
+
+
−
+
−
−
+
+
−
+
+
−
+
+
+
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
*As assessed by measurement of the diameter (mm) of the zone
of the inhibited growth of the indicator strain, inclusive of the well
diameter (5 mm), where ‘+’ indicates a diameter of the zone of
growth inhibition of 7 mm or greater and ‘−’ indicates a diameter
of inhibited growth of less than 7 mm
Table 3 Physicochemical characterization of the
inhibitor produced by E. faecium strain 62-6 against the
sensitive Lactobacillus indicator strain 4-1 and the resist-
ant strain 62-5. All assays were carried out following
growth of strain 62-6 in MRS broth and assayed for
inhibitory activity by well diffusion on MRS agarwhich coincided with mid to late log phase of
growth. Interestingly, the onset of inhibitor
production was sudden, corresponding to a
concentration of strain 62-6 of ca. 107 cfu/ml or
greater. It also appeared rapid, as opposed to
accumulating gradually in the culture supernatant
over time. Such observations suggest that the
regulation of inhibitor production may be subject
to quorum sensing29, where a bacterial population
reaches a critical concentration before switching
on (or off) production of a particular metabolic
pathway.
DISCUSSION
While positive interactions between microbial
populations of significance during BV have been
demonstrated30–32, the aim of this study was to
examine the production of antagonistic substances
by microbial populations of vaginal origin which
could lead to the disappearance of the lactobacilli
and potentially pave the way for the establishment
of a BV-associated microflora. In 1961, Pohunek33
brieflydescribedenterococciisolatedfromwomen
with a disturbed vaginal microflora that were
antagonistic to the growth of vaginal lactobacilli,
however the nature of the inhibitory activity was
not investigated. James and Tagg27 preliminarily
reported one enterococci strain of vaginal origin,
E. faecalis ssp. liquefaciens T142, which produced
both blood-dependent and blood-independent
inhibitors antagonistic to the growth of vaginal
lactobacilli. Tao16 described possible bacteriocins
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Figure 1 Kinetics of inhibitor production over time. Results represent the means and standard deviations of three
independent experiments. The concentration of E. faecium strain 62-6 (l) was determined by plate count on BA. The
inhibitory activity against indicator strain 4-1 (s) was determined using the well diffusion assay. The width of the zone
of inhibition was obtained by subtracting the 5 mm diameter of the well from the diameter of the zone of inhibition
Producer strain
Inhibition of endogenous Lactobacillus
indicator strain
62-5 46-1 46-4
62-6
46-2
−
NA
NA
−
NA
−
*Strains 62-5 and 62-6 were isolated from a different woman than
strains 46-1, 46-2 and 46-4. NA, not applicable
Table 4 Production of inhibitory activity by E. faecium
strain 62-6 and E. faecalis strain 46-2 against strains of
lactobacilli isolated from the same subject*, as assayed
using both the deferred antagonism technique and the
well diffusion assay, on BAproduced by lactobacilli from nonvaginal
sources which inhibited the growth of vaginal
lactobacilli; however, these inhibitors have yet to
be characterized in detail. With the exception of
the aforementioned studies, the hypothesis that
vaginally-derived streptococci (including entero-
cocci) produce bacteriocins antagonistic to the
growth of vaginal lactobacilli has not been
addressed. In initial studies undertaken to address
this hypothesis we tested 70 vaginal isolates of
streptococci and enterococci for their ability to
produce bacteriocin-like inhibitors against 32
vaginal lactobacilli using the deferred antagonism
technique. This study reports the physicochemical
characterization of the inhibitor produced by one
strain, E. faecium 62-6, which strongly inhibited
the growth of vaginal lactobacilli.
ThespectrumofinhibitoryactivityofE.faecium
strain 62-6 was essentially limited to Gram-
positiveorganismsfromthesameecologicalniche,
including closely-related genera and vaginal lacto-
bacilli. This finding is similar to that reported for
thebacteriocinproducedbyStreptococcuszymogenes
(now E. faecalis var. zymogenes)34 and consistent
with bacteriocins produced by other lactic acid
bacteria,whichofteninhibitthegrowthofbacteria
outside their own genus19,20.
Characterization experiments were performed
to determine the nature of the blood-independent
inhibitory activity by strain 62-6 using inhibitor-
containing MRS broth culture supernatants. We
initially established that the inhibitory effect
against sensitive indicator bacteria was not due to
the production of acid conditions or hydrogen
peroxide alone, effects that have often been
reported to mimic bacteriocin-like inhibition28.
We then demonstrated that the inhibitor was both
heat, cold and pH stable, surviving exposure to
temperatures in the range 50°C to 100°C for
30 minutes (but not autoclaving), storage at 4°C
for at least 114 days and exposure to conditions in
thepHrange4.0to7.0,respectively.Theinhibitor
adsorbed to cellulose membranes during filtration.
These properties are consistent with those
previously reported for bacteriocin-like inhibitors
produced by lactic acid bacteria18.
Anessentialdefiningcharacteristicofabacterio-
cin is a proteinaceous component18. Inhibitor-
containing MRS broth culture supernatants were
sensitive following exposure to the proteolytic
agents pepsin and α-chymotrypsin. These super-
natants were, however, resistant to the proteinases
trypsin and proteinase K. Differential sensitivity to
a panel of proteases has been frequently reported
for other bacteriocin-like inhibitors18. The inhibi-
tor was resistant to lysozyme but sensitive to lipase,
which may indicate that it contains an essential
lipid component. The inability of the inhibitor to
dialyze through membranes of molecular mass
cut-off of 12 000 Da (or less) estimates that the
molecular mass is greater than this. Future
characterization assays using the chemically-
purifiedinhibitorwillallowustomoredefinitively
characterize the physicochemical properties of
this inhibitor. This will enable us to determine
how this bacteriocin fits into the classification
scheme as described by Klaenhammer20, including
whether it could be a class IV (complex) bacterio-
cin. However, all characteristics presented above
for the inhibitor produced by strain 62-6 are
consistent with those for previously-described
bacteriocin-like inhibitors.
For two inhibitor-producing strains of
E. faecium, strains 62-6 and 46-2, strains of lacto-
bacilliisolatedfromthesamesubjectwereimmune
to inhibitor action. This observation suggests
that the bacteriocin targets lactobacilli outside the
original host while the endogenous strains are
immune. Though preliminary, this finding is eco-
logically significant. It is also consistent as part of
our original hypothesis that formed the basis for
this study, that multiple sex partners, in particular
the onset of a new sex partner, provides the
opportunity for the acquisition of new strains of
vaginal bacteria. If a bacteriocin-producing strain
ofEnterococcus from another host is introduced into
the vaginal tract via sexual intercourse, it may be
antagonistic to the growth of the endogenous
lactobacilli present and cause their decline. This
may,inturn,leadtotheovergrowthofaerobesand
anaerobes associated with BV.
One of the most striking findings during this
study was the demonstration of inhibitor pro-
duction following a minimum concentration of
strain 62-6 of ca. 107 cfu/ml, which suggests that
regulation of inhibitor production is controlled via
quorum sensing29. The presence of enterococci in
the vaginal tract has been associated with a healthy
Vaginal lactobacillus inhibition Kelly et al.
154 • INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYvaginal microflora although levels do not always
exceed 107 cfu/ml22. However, if our in vitro
observation applies in vivo, when present in high
enough levels, bacteriocinogenic enterococci
producing inhibitors antagonistic to the growth of
vaginal lactobacilli may be one mechanism to
account for the establishment of a BV-associated
microflora.
This result may be of considerable clinical
significance as one mechanism accounting for the
high recurrence rate of BV following antibiotic
therapy when the overgrowth of enterococci is a
frequent, persistent problem. In clinical studies
using topical clindamycin cream to treat BV,
enterococci were reported to increase in preva-
lence from low (range, 0 to 11%) to high
levels (range, 47 to 62%)35,36 following therapy.
Persistence of enterococci in approximately 50%
of women 1 month after treatment for BV was
reported by Hillier and co-workers36. While con-
centrations of persistent enterococci in the study
reported by Hill and Livengood35 did not exceed
107 cfu/ml, the critical concentration at which we
have shown inhibitor production to occur in vitro,
it is conceivable that these levels could be reached
insomesubjects.Thus,forwomenwhohavebeen
treated with antibiotics for BV and who become
colonized with high concentrations of bacterio-
cinogenic strains of enterococci such as strain
62-6, bacteriocin production may prevent estab-
lishment of the normal microflora. This could be a
novel mechanism contributing to the high recur-
rence rate of BV. Clinical studies addressing the
prevalence, concentration and bacteriocinogenic
potentialofpersistententerococcalstrainsinrecur-
rent BV subjects would address the significance of
this as a mechanism to account for recurrent BV.
Understanding the interactions among micro-
organisms which comprise the normal vaginal
microflora as well as factors which disrupt this
ecological balance and lead to the establishment of
BV has been proposed by several researchers4,37,38.
Such information will solve some of the mysteries
surrounding the pathogenesis of BV. Ultimately,
theelucidationofsuchmechanismswillopennew,
ecologically-based procedures for the control of a
syndromewhereantibiotictreatmenthassoclearly
been ineffectual1.
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